BioInvent Announces Promising Data for BI-1910 as Single Agent from Phase 1 Study in Solid ...
BI-1910 single agent Phase 1 Part A dose escalation has been completed and reached a biologically active dose level. Data ...
BioInvent International: BioInvent Announces Promising Data for BI-1910 as Single Agent ...
LUND, SWEDEN / ACCESSWIRE / January 8, 2025 / BioInvent International (STO:BINV)BI-1910 single agent Phase 1 Part A dose escalation has been completed and reached a biologically active dose level. Dat ...